Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.

The article focuses on a report regarding reactivation of multiple sclerosis (MS) patients after discontinuation of the drug fingolimod (FTY). It informs Fingolimod is an oral drug used for the treatment of relapsing remitting (RR) MS. It informs that the drug reduce inflammation by preventing lymphocytes from entering central nervous system.